Table 3.
PTMs identified exclusively in the CP cohort.
|
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Frequency of modification per 1,000 potential modification sites | ||||||||||
|
| ||||||||||
| #CP | CP1 | CP2 | CP3 | CP4 | CP5 | CP6 | CP7 | CP8 | CP9 | |
| Acetyl(K) | 2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.11 |
| Carbamyl(R) | 1 | 0.00 | 0.00 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Carboxy(K) | 2 | 0.14 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Carboxyethyl(K) | 4 | 0.14 | 0.00 | 0.00 | 0.12 | 0.00 | 0.09 | 0.13 | 0.00 | 0.00 |
| Dichloro(Y) | 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| Hex(S) | 2 | 0.07 | 0.00 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Hex(T) | 3 | 0.11 | 0.00 | 0.11 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Nicotinyl(K) | 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 |
| Trioxidation(Y) | 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 | 0.00 |
CP, no pancreatitis (controls); #CP, number of CP samples in which a specific PTM has been identified.